Abstract
Purpose
Children undergoing chemotherapeutic treatment of malignancies have up to a 9 % incidence of osteonecrosis. The purpose of this article is to determine the time from initiation of chemotherapy to the onset of symptoms and the diagnosis of osteonecrosis of the femoral head in this patient population.
Methods
A retrospective review of the records of 18 patients (29 hips) under 21 years of age with both a diagnosis of osteonecrosis of the femoral head and childhood onset malignancy was undertaken to determine the time from initiation of chemotherapy to the onset of symptoms and diagnosis of osteonecrosis of the femoral head.
Results
Mean time from initiation of chemotherapy to the onset of pain was 18.8 months (8.0–49.1). The mean time from development of pain to diagnosis of osteonecrosis was 3.9 months (−13.1 to 25). The mean overall time from initiation of chemotherapy to diagnosis of osteonecrosis was 22.7 months (9.0–54.1). 11/18 patients had bilateral disease. 16/18 patients (21/29 hips) had already progressed to stage 4 osteonecrosis at the time of diagnosis.
Conclusions
There was a high incidence of stage 4 or greater osteonecrosis at the time of diagnosis. Providers caring for these patients should be aware of the potential for osteonecrosis, and the need for prompt diagnosis and referral to an orthopedic surgeon. Screening with advanced imaging studies may be warranted for children undergoing chemotherapeutic regimens for childhood malignancy to prevent delay in the diagnosis and management of this process so that joint preservation therapies remain an option.
Similar content being viewed by others
References
Mattano LA Jr, Sather HN, Trigg ME, Nachman JB (2000) Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children’s Cancer Group. J Clin Oncol 18:3262–3272
Madadi F, Shamsian BS, Alavi S, Madadi F, Eajazi A, Aslani A (2011) Avascular necrosis of the femoral head in children with acute lymphoblastic leukemia: a 4- to 9-year follow up study. Orthopedics 34:593–597
Barr RD, Sala A (2008) Osteonecrosis in children and adolescents with cancer. Pediatr Blood Cancer 50:483–485
Stubbs AJ, Gunneson EB, Urbaniak JR (2005) Pediatric femoral avascular necrosis after pyarthrosis. Clin Orthop Relat Res 439:193–200
Ribiero RC, Fletcher BD, Kennedy W, Harrison PL, Neel MD, Kaste SC et al (2001) Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-hodgkin lymphoma. Leukemia 15:891–897
Ojala AE, Lanning FP, Paakko E, Lanning BM (1997) Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment. Med Pediatr Oncol 29:260–265
Burger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M (2005) Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from Trial ALL-BFM 95. Pediatr Blood Cancer 44:220–225
Motomura G, Yamamoto T, Miyanishi K et al (2005) Bone marrow fat cell enlargement in early steroid-induced osteonecrosis: a histomorphometic study of autopsy cases. Pathol Res Pract 200:807–811
Aldridge JM III, Urbaniak JR (2004) Avascular necrosis of the femoral head: eitiology, pathophysiology, classification, and current treatment guidelines. Am J Orthop 7:327–332
te Winkel ML, Pieters R, Hop WCJ, de Groot-Kruseman HA, Lequin MH, van der Sluis IM et al (2011) Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol 29:4143–4150
Wei SY, Esmail AN, Bunin N, Dormans JP (2000) Avascular necrosis in children with acute lymphoblastic leukemia. J Pediatr Orthop 20:331–335
Lackner H, Benesch M, Moser A, Smolle-Juttner F, Linhart W, Raith J et al (2005) Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: a 13-year longitudinal observational study. J Pediatr Hematol Oncol 27:259–263
Karimova EJ, Rai SN, Ingle D, Ralph AC, Deng X, Neel M et al (2007) Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol 25:1525–1531
Patel B, Richards SM, Rowe JM, Goldstone AH, Fielding AK (2008) High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis. Leukemia 22:308–312
Nunimaki RA, Harila-Saari AH, Jartti AE, Seuri RM, Riikonen PV, Paakko EL et al (2007) High body mass Index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J Clin Oncol 25:1498–1504
Aldridge JM III, Berend KR, Gunneson ER, Urbaniak JR (2003) Free vascularized fibular grafting for the treatment of postcollapse osteonecrosis of the femoral head. Surgical technique. J Bone Joint Surg Am 85A:987–993
Agarwala S, Jain D, Joshi VR, Sule A (2005) Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology 44:352–359
Greggio NA, Pillon M, Varotto E, Zanin A, Talenti E, Palozzo AC et al (2010) Short-term bisphosphonate therapy could ameliorate osteonecrosis: a complication in childhood hematologic malignancies. Case Rep Med 2010:206132
Kotecha RS, Powers N, Lee SJ, Murray KJ, Carter T, Cole C (2010) Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 54:934–940
Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM (2005) The use of alendronate to prevent early collapse of the femoral head in patients with non traumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am 87A:2155–2159
Dean GS, Kime RC, Fitch RD, Genneson E, Urbaniak JR (2001) Treatment of osteonecrosis in the hip of pediatric patients by free vascularized fibular grafting. Clin Orthop Relat Res 386:106–113
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Mayer, S.W., Mayer, B.K., Mack Aldridge, J. et al. Osteonecrosis of the femoral head in childhood malignancy. J Child Orthop 7, 111–116 (2013). https://doi.org/10.1007/s11832-012-0471-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11832-012-0471-6